Study your flashcards anywhere!

Download the official Cram app for free >

  • Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

A key: Read text to speech.a key

image

Play button

image

Play button

image

Progress

1/19

Click to flip

19 Cards in this Set

  • Front
  • Back
Name 3 groups of antiplatelets?
glycoprotein IIb/IIIa
inhibitors
platelet adhesion inhibitors
platelet aggregation
inhibitors
Name two glycoprotein IIb/IIIa inhibitors?
eptifibatide Integrilin
tirofiban Aggrastat
Name one platelet adhesion
inhibitor?
dipyridamole {Apo-Dipyridamole}, Dipridacot, {Novodipiradol}, Persantine, Persantine IV
Name 3 platelet aggregation inhibitors?
cilostazol Pletal

clopidogrel Plavix

ticlopidine Ticlid
Antiplatelet agents are used to treat and prevent _____ events such as stroke and MI.
thromboembolic
_______ is commonly used after cardiac surgery.
Dipyridamole
Which 4 agents are used to inhibit platelet aggregation, prolong bleeding time, and prevent MI or stroke?
aspirin
clopidogrel
dipyridamole
ticlopidine
Which two agents are used in the management of various acute coronary syndromes?
eptifibatide
tirofiban

These agents have been used concurrently/sequentially with anticoagulants and thrombolytics.
Antiplatelets are contraindicated in these 4?
hypersensitivity
ulcer disease
active bleeding
recent surgery
Use antiplatelets cautiously in patients at risk for? (4)
bleeding from trauma
bleeding from surgery
GI bleed
ulcer disease
Safety of platelets has not been established in pregnancy, lactation, or children.
okay
Concurrent use with which 4 agents may increase the risk of bleeding?
NSAIDs
heparin
thrombolytics
warfarin
Assess patient for evidence of additional or increased ____. Symptoms will depend on area of involvement.
thrombosis
Assess patient taking antiplatelet agents for symptoms of (3) periodically throughout therapy.
stroke
peripheral vascular disease
MI
Monitor _____ time throughout antiplatelet therapy. Prolonged bleeding time, which is time- and dose-dependent, is expected.
bleeding
Potential Nursing Diagnoses?
(3)
Tissue perfusion, ineffective
Injury, risk for
Knowledge, deficient, related
to disease processes and
medication regimen
Use an infusion pump with _____ infusions to ensure accurate dosage.
continuous
Instruct patient to notify hcp immediately if any _____ is noted.
bleeding
Effectiveness of therapy can be demonstrated by? (3)
prevention of stroke, MI, and vascular death in patients at risk